Form D — OncoResponse, Inc
0001123292-25-000198 · filed May 6, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 506(b)
- Reported offering amount
- —
- Reported amount sold
- $5,999,138
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- OncoResponse, Inc
- CIK
- 1655774
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 609 MAIN STREET
HOUSTON, Texas 77002 - Phone
- (206) 805-1600
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Clifford J. Stocks · DirectorHOUSTON, Texas Find on LinkedIn ↗
-
Alice Bexon · Executive OfficerHOUSTON, Texas Find on LinkedIn ↗
-
Kamal D. Puri · Executive OfficerHOUSTON, Texas Find on LinkedIn ↗
-
Chris Russell · Executive OfficerHOUSTON, Texas Find on LinkedIn ↗
-
Roberto De Ponti · DirectorHOUSTON, Texas Find on LinkedIn ↗
-
Carol Gallagher · DirectorHOUSTON, Texas Find on LinkedIn ↗
-
Steven Gillis · DirectorHOUSTON, Texas Find on LinkedIn ↗
-
Wende Hutton · DirectorHOUSTON, Texas Find on LinkedIn ↗
-
Sean A. McCarthy · DirectorHOUSTON, Texas Find on LinkedIn ↗
-
John McKearn · DirectorHOUSTON, Texas Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗